Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000017

Options or other derivatives

  • EVP, Chf Clinical Develop Ofcr acquired 22,942 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schneider Eugene · EVP, Chf Clinical Develop Ofcr

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-01-03 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +22,942 $37.58 2033-01-02 22,942 22,942 D
Loading xslF345X03/edgardoc.xml…